ask="N/A"
ask_size="N/A"
average_daily_volume="36576"
bid="N/A"
bid_size="N/A"
book_value="0.0000"
change="+0.2508"
change_from_200_day_moving_average="-1.5552"
change_from_50_day_moving_average="-0.4877"
change_from_52_week_high="-10.2192"
change_From_52_week_low="0.4308"
change_in_percent="+8.8622%"
close="3.0808"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-11.2650"
ebitda="0.00"
eps_estimate_current_year="-5.0600"
eps_estimate_next_quarter="-0.8400"
eps_estimate_next_year="-3.1800"
ex_dividend_date="N/A"
float_shares="N/A"
high="3.1200"
high_52_weeks="13.3000"
last_trade_date="1/3/2017"
last_trade_price="3.0808"
last_trade_size="1000"
last_trade_time="3:59pm"
low="2.8500"
low_52_weeks="2.6500"
market_capitalization="N/A"
moving_average_200_day="4.6360"
moving_average_50_day="3.5685"
name="Caladrius Biosciences
Inc."
notes="N/A"
one_year_target_price="11.1700"
open="2.8500"
pe_ratio="N/A"
peg_ratio="-0.0100"
percent_change_from_200_day_moving_average="-33.5460%"
percent_change_from_50_day_moving_average="-13.6666%"
percent_change_from_52_week_high="-76.8361%"
percent_change_from_52_week_low="+16.2566%"
previous_close="2.8300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="CLBS"
volume="41606"
weeks_range_52="2.6500 - 13.3000"
